causing rapidly progressive glomerulonephritis and
Introduction
possible donor species for xenografting.
In this study we have determined the a3(IV )NC1 Goodpasture's, or antiglomerular basement membrane cDNA sequence from five additional mammalian (anti-GBM ) disease is a rare autoimmune disorder species, so that nine sequences can now be compared.
For selected species this has been related to the immuCorrespondence and offprint requests to: Neil Turner, Department of noreactivity of their collagenase-solubilized-GBM pre- 
Preparation of collagenase-solubilized glomerular

Subjects and methods basement membrane (CS-GBM) cDNA amplification and sequencing
The method was based on those described by Spiro and Westberg, as reported previously [6 ] . Cortex from partially Total RNA was purified from fresh or snap-frozen renal thawed kidneys was minced and forced through a 150-mm cortex by the guanidinium thiocyanate/phenol/chloroform stainless steel sieve, and repeatedly washed with cold PBS. method. Five to twenty micrograms of total RNA was The sieve used for rat kidneys was 106 mm. Separated glomerreverse-transcribed using AMV reverse transcriptase (Life uli were passed through a 250-mm sieve to remove large Sciences Inc.) and oligo-dT. One twentieth to 1/50 of each fragments and collected on a 63-mm sieve. Isolated glomeruli reaction was then used in each PCR amplification. were then washed three times in cold PBS and examined by Oligonucleotide primers (Figure 1 ) used were (5∞ to 3∞) light-microscopy to ensure that tubular contamination was 1: CCCTGATCAAACCACAGCAATTCC.
less than 5%. Further preparation and digestion with colla-2: GGTGCATGCACACCTGACA. genase was as previously described; 5 mM N-ethylmaleimide, 3: AAGCCTATTCCATCAACTGTG.
1 mM phenylmethyl sulphonyl fluoride, and 25 mM amino4a: GGAAACAAATTGAAACTTTGT.
n-caproic acid were added as protease inhibitors to all 4b: TTGTGTAGTGAAACTTTGCA.
digestions except for those with human GBM. Several preparations of the the more weakly reacting CS-GBM prepara4b was substituted for 4a for amplification of rat cDNA. tions were compared, varying the addition of protease The sequences were based on the human a3(IV )NC1 cDNA inhibitors and time of collagenase digestion. When differences sequence, except for 4b, which was based on the murine 3∞ were observed, the most strongly reacting preparations were non-coding sequence in this region, kindly made available used in all comparative studies. by Dr Paul Killen. Thirty cycles of amplification were performed using Taq polymerase (Perkin Elmer-Cetus) and 1-min periods at 94°C, 55°C and 72°C. PCR products were ELISA purified by agarose gel electrophoresis, digested with the restriction enzymes Bgl1 and Sph1 (product using primers 1 CS-GBM was coated to 96-well ELISA plates (Nunc) at and 2) or phosporylated (product using primers 3 and 4) 4 mg/well in 6 M guanidine Hcl/50 mM Tris-HCl pH 7.5 at and ligated into M13mp18 and 19. Single-stranded DNA 4°C overnight. Goodpasture's or control serum was added was sequenced by dideoxy chain termination using modified to the coated wells and incubated at 37°C for 1 h. Bound T7 DNA polymerase (Sequenase, USB) and incorporation IgG was detected by alkaline-phosphatase-conjugated goat of 35S-dATP. Multiple clones from each species were exam-anti-human IgG (Sigma), and quantitation performed by ined to exclude PCR errors. To extend the rat a3(IV )NC1 colour development with p-nitrophenylphosphate and meascDNA, 107 plaques of a rat kidney cDNA library in phage urement of absorbance at 405 nm. l (Clontech) were screened using 32P-labelled, RT-PCRderived partial cDNAs.
SDS-PAGE and immunoblotting
Antibodies CS-GBM was run in 5-20% SDS-PAGE gels at 50 mg per lane without reducing agents, and silver-stained or elecPatients' sera were obtained at the time of diagnosis of acute troblotted to 0.45 mm pore nitrocellulose membranes Goodpasture's disease. Some 'sera' were aliquots from the (Schleicher and Schuell ). Filters were blocked by washing in first litre of plasma removed during the first or second PBS/0.5% Tween 20 (PBS/Tw) for 30 min at room tempertherapeutic plasma exchange treatment.
ature, and the primary antibody applied in PBS/Tw for one h at room temperature. Three 5-min washes with PBS/Tw were performed between stages. Specifically bound IgG was Tissue identified using alkaline-phosphatase-conjugated secondary antibodies (Sigma) with nitroblue tetrazolium and 5-bromoHuman tissue was obtained at autopsy within 12 h of death 4-chloro-3-indolyl phosphate (Sigma) as substrate. The conor from the normal pole of a kidney removed because of centration of the primary antibody was adjusted to give malignancy. Other species studied were New-World monkey strong binding to the lane containing human GBM within (macaque), domestic sheep, ox, horse, pig, dog, rabbit, and 15 min of the addition of substrate (1540 to 15100), but rat (Sprague-Dawley). Tissue was obtained immediately normal human serum was used at 158. after death and frozen at −20°C for GBM preparation. Tissue snap-frozen in liquid nitrogen and stored at −80°C was used for immunofluorescence studies and for RNA Results preparation.
a3(IV)NC1-derived amino-acid sequences
Oligonucleotide primers were designed to amplify a3(IV ) cDNAs from mixed first-strand cDNAs that should include other a chain sequences. Primer 2 in Figure 1 should be a general primer for all type IV collagen chains, but primers 1 and 3 were to a3-chain from the non-coding region of a3(IV ) mRNA, having previously been fortuitously found to amplify a3(IV ) sequences from genomic DNA of other species. Complete sequences were obtained for 3 of 5 species over the region studied. A product was not obtained with primers 1 and 2 from horse or dog cDNA, and a product was not obtained with primers 3 and 4 from pig or rabbit cDNA, presumably because of base changes in the region of primers 1 and 4 respectively, as the region encompassing the other primer was sequenced in each case. Of several rat a3(IV ) NC1 cDNAs isolated from a rat kidney cDNA library, one extended 5∞ into the collagenous region, enabling extension of the sequence to include the entire NC1 domain. The derived amino acid sequences that were obtained are shown in Figure 2 , alongside previously published sequences.
The overall derived amino acid sequence homologies with the human a3 chain over the region between primers 1 and 2 were monkey 99%, rabbit 95%, ox, Human a1 and a5 chains show 74% and 70% homology with a3 over this region; these form the a1-like group of type IV collagen chains. a2, a4 and ELISA a6(IV ) fall into a different group with similar degrees of homology to each other but less (54-64%) to the Collagenase digests were coated to ELISA plates at approximately 5 mg/well, and dilution curves a1-like chains. . Monkey, sheep, pig, rabbit, and rat sequences, and dog sequence between residues 210 and 229, are from this work. They have been submitted to GenBank with the accession numbers L47280, L47282, L47284, L47283, and L47281 respectively. cDNAs encoding the COOH-terminal 9 residues of the pig and rabbit molecules were not obtained. Human a3, a1, and a5 and mouse, bovine, and dog a3 sequences have been previously published [6-12]. Minor differences from the originally published complete human a3(IV )NC1 sequence are corrected in sequence databases (GenBank M81379
tions. Monkey GBM gave closely similar results to the same for each. Sera were those obtained at presentation from four patients deliberately selected for human GBM. Horse, sheep, and bovine GBM were 
SDS-PAGE and immunoblotting
The reactivity of components with Goodpasture autoantibodies by Western blotting is shown in Figure 5 . Different sera showed essentially identical patterns of reactivity. Binding was strongest to the NC1 dimer region, but more variable to monomers, probably because there is more protein present in the Fig. 6 . Western blot of SDS-PAGE-separated human and rat GBM dimer region, and a single monomer may produce overlaid with anti-a3(IV )NC1-specific antipeptide antibodies. Rat several bands by dimerizing with different isoforms. In GBM is shown to the left and human GBM to the right. 1V and 3V indicate binding of anti-a1 and anti-a3 chain antipeptide antibodthe monomer region the strongest reactivity was seen ies. G1 and G2 are Goodpasture sera. Despite the poor recognition to human and monkey GBM. Bovine, horse, and sheep of rat a3(IV )NC1 monomer by human autoantibodies, the antipepmonomers reacted approximately equally and only tide antibodies clearly identify that it is present. slightly less strongly. Rat monomers reacted weakly. As later conclusions are based on the analysis of the difference in the reactivity of rat GBM, studies with the rat has the lowest overall degree of sequence antipeptide antibodies were undertaken to confirm that homology, only the monkey has greater homology in the rat GBM preparations contained a3(IV )NC1 the carboxyl region, residues 166-230 ( Figure 2) , of monomers. A rabbit antiserum raised to the human the NC1 domain: homology with the human sequence a3(IV )NC1 peptide LASLNPERM (residues 193-201 is 97% for the rat, versus 91% for the bovine and sheep in Figure 2 ), a sequence that is identical to the rat sequence. The mouse sequence is surprisingly only 95% a3(IV )NC1 sequence in this region, strongly identified identical to the rat sequence obtained in this study both rat a3(IV )NC1 dimers and the monomer bands (and 92.5% to the human) [12] , but like the rat that human autoantibodies bind to only weakly sequence is very similar to the human sequence in the ( Figure 6 ).
COOH-terminal region. The remarkable similarity of this region in otherwise divergent species indicates that there is selective pressure to maintain the precise Discussion sequence. In this region, which has been proposed to include most of a major epitope for Goodpasture The differences between the a3(IV )NC1 sequence and autoantibodies on the basis of peptide-binding studies that of a1 and a5 chains are shown in Figure 2 . There [13], residues 195 to 221, the rat and human sequences, are 32 'chain-specific' residues, common to all the are identical apart from a conservative aspartic-to a3(IV )NC1 sequences but different from al/a5. These glutamic-acid change at position 214. This compares may be critical to the specific function of a3(IV ). with three significant changes in the bovine sequence Some of the other differences between a3 and a1/a5 in this region and one in the sheep, both of which bind that are not constant between species are conservative, autoantibodies strongly. This cannot account for the and may also be chain-specific. The inter-species observation that bovine GBM and rat GBM bind a3(IV )NC1 sequence homologies range from 99% for strongly and weakly respectively to human antibodies. human5monkey to 91% for human5rat. However, the If this loop is indeed part of a major Goodpasture differences between rat and human a3(IV )NC1 amino-epitope, it must act in combination with another region acid sequences are very unevenly distributed. Although of a3(IV )NC1 where the differences between species are greater. Several strands of evidence point towards the amino-terminal of the NC1 domain. Penades et al. [14] found that recombinant polypeptide which retained the amino region but lacked a significant portion of the carboxyl region bound to human autoantibodies. A recent study has suggested that the principal B cell epitope is formed by the association of amino and carboxyl regions [15] . The involvement of two distant parts of a molecule in an antibody-binding site is of course common; many and possibly most B cell epitopes are discontinuous [16 ] . When crude GBM preparations containing NC1 domains of multiple a( IV ) chains are used to immunize immune response that ensues has been shown to be 1993; 268: 26033-26036 bovine NC1 domains into rabbits showed that the 5. Kashtan CE, Michael AF. Alport syndrome. Kidney Int 1996; a3-containing fractions were consistently the nephrito- are the same as in the human prototype. 
